Miller, W. (1985). Herkovits v. Group Health
The 21st century has brought a great number of changes to the medical paradigm, however. As the population ages, there are more and more people requiring care; and more who have or are experiencing debilitating conditions that, up to now, have had no medical or pharmacological treatment. The contemporary physician, therefore must respect patient value and individuality, the education of the patient, as well as provide the best service possible under the realities of contemporary medical care. At times, this may result in working with an experimental procedure or drug that may not have predictable effects and may actually go against the medical paradigm of "do no harm," while staying to the letter of the ethical maxim of "intentionally do no harm"
MRSA infection: diagnosis, treatment, prevention, and economic impacts
This paper discusses the infection trajectory Methicillin-resistant Staphylococcus aureus (MRSA). The paper introduces the development of the bacterium in its most common iterations. The nature of the infection including symptoms, treatment options which are limited, and efforts from the health community are evaluated. Of particular importance is the portion concerning the differences between the communities based version and the nosocomial version.